Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma
Status:
Completed
Trial end date:
2018-05-30
Target enrollment:
Participant gender:
Summary
Safety and tolerability of three different concentrations (0.1%, 03%, 0.6%) of the
investigational SHP639 eye drops will be evaluated in participants with high eye pressure or
primary open-angle glaucoma.